Your browser doesn't support javascript.
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges.
Oliveira, Rudolf K F; Nyasulu, Peter S; Iqbal, Adeel Ahmed; Hamdan Gul, Muhammad; Ferreira, Eloara V M; Leclair, John William; Htun, Zin Mar; Howard, Luke S; Mocumbi, Ana O; Bryant, Andrew J; Tamuzi, Jacques L; Avdeev, Sergey; Petrosillo, Nicola; Hassan, Ahmed; Butrous, Ghazwan; de Jesus Perez, Vinicio.
  • Oliveira RKF; Division of Respiratory Diseases, Department of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  • Nyasulu PS; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
  • Iqbal AA; National Health System (NHS), Global Clinical Network, London, United Kingdom.
  • Hamdan Gul M; Department of Internal Medicine, University of Kentucky, Lexington, KY, United States.
  • Ferreira EVM; Division of Respiratory Diseases, Department of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  • Leclair JW; Department of Medicine, Stanford University, Stanford, CA, United States.
  • Htun ZM; Division of Pulmonary and Critical Care, National Institute of Health, University of Maryland, College Park, College Park, MD, United States.
  • Howard LS; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Mocumbi AO; Faculty of Medicine, Universidade Eduardo Mondlane, Maputo, Mozambique.
  • Bryant AJ; Non-communicable Diseases Division, Instituto Nacional de Saúde, Marracuene, Mozambique.
  • Tamuzi JL; College of Medicine, University of Florida, Gainesville, FL, United States.
  • Avdeev S; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
  • Petrosillo N; Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Hassan A; Infection Prevention and Control-Infectious Disease Service, Foundation University Hospital Campus Bio-Medico, Rome, Italy.
  • Butrous G; Department of Cardiology, Cairo University, Cairo, Egypt.
  • de Jesus Perez V; Medway School of Pharmacy, University of Kent at Canterbury, Canterbury, United Kingdom.
Front Med (Lausanne) ; 9: 1041236, 2022.
Article in English | MEDLINE | ID: covidwho-2163043
ABSTRACT
COVID-19 infection primarily targets the lungs, which in severe cases progresses to cytokine storm, acute respiratory distress syndrome, multiorgan dysfunction, and shock. Survivors are now presenting evidence of cardiopulmonary sequelae such as persistent right ventricular dysfunction, chronic thrombosis, lung fibrosis, and pulmonary hypertension. This review will summarize the current knowledge on long-term cardiopulmonary sequelae of COVID-19 and provide a framework for approaching the diagnosis and management of these entities. We will also identify research priorities to address areas of uncertainty and improve the quality of care provided to these patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Long Covid Language: English Journal: Front Med (Lausanne) Year: 2022 Document Type: Article Affiliation country: Fmed.2022.1041236

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Long Covid Language: English Journal: Front Med (Lausanne) Year: 2022 Document Type: Article Affiliation country: Fmed.2022.1041236